ECSP045145A - Uso de inhibidores de la recaptacion de norepinefrina para el tratamiento del fallo cognitivo - Google Patents

Uso de inhibidores de la recaptacion de norepinefrina para el tratamiento del fallo cognitivo

Info

Publication number
ECSP045145A
ECSP045145A EC2004005145A ECSP045145A ECSP045145A EC SP045145 A ECSP045145 A EC SP045145A EC 2004005145 A EC2004005145 A EC 2004005145A EC SP045145 A ECSP045145 A EC SP045145A EC SP045145 A ECSP045145 A EC SP045145A
Authority
EC
Ecuador
Prior art keywords
inhibitors
norepinefrine
recaptation
cognitive failure
failure treatment
Prior art date
Application number
EC2004005145A
Other languages
English (en)
Inventor
Franklin Porter Bymaster
Donald Richard Gehlert
David Lee Mckinzie
Charles Renkin Yang
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of ECSP045145A publication Critical patent/ECSP045145A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Inhibidores selectivos de la recaptación de norepinefrina, particularmente atomoxetina, reboxetina y fenoxifenilpropilaminas 2-alquiltiosustituidas, se usan para el tratamiento del fallo cognitivo, incluyendo el fallo cognitivo debido a demencia, delirio y esquizofrenia.
EC2004005145A 2001-12-11 2004-06-09 Uso de inhibidores de la recaptacion de norepinefrina para el tratamiento del fallo cognitivo ECSP045145A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US33917401P 2001-12-11 2001-12-11

Publications (1)

Publication Number Publication Date
ECSP045145A true ECSP045145A (es) 2004-07-23

Family

ID=23327833

Family Applications (1)

Application Number Title Priority Date Filing Date
EC2004005145A ECSP045145A (es) 2001-12-11 2004-06-09 Uso de inhibidores de la recaptacion de norepinefrina para el tratamiento del fallo cognitivo

Country Status (26)

Country Link
US (1) US20050009925A1 (es)
EP (1) EP1458368B1 (es)
JP (1) JP2005517647A (es)
KR (1) KR20040066895A (es)
CN (1) CN1713900A (es)
AU (1) AU2002352625A1 (es)
BR (1) BR0213581A (es)
CA (1) CA2467802A1 (es)
CO (1) CO5590907A2 (es)
CZ (1) CZ2004709A3 (es)
DE (1) DE60223718T2 (es)
EA (1) EA200400793A1 (es)
EC (1) ECSP045145A (es)
ES (1) ES2295435T3 (es)
HR (1) HRPK20040528B3 (es)
HU (1) HUP0402619A3 (es)
IL (1) IL161989A0 (es)
MX (1) MXPA04005716A (es)
MY (1) MY136367A (es)
NO (1) NO20042904L (es)
NZ (1) NZ532065A (es)
PL (1) PL369311A1 (es)
SK (1) SK2442004A3 (es)
TW (1) TW200300672A (es)
WO (1) WO2003049724A1 (es)
ZA (1) ZA200404274B (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA05001705A (es) * 2002-08-14 2005-04-19 Pharmacia & Upjohn Co Llc Uso de reboxetina para el tratamiento de sofocos.
WO2005011583A2 (en) * 2003-07-28 2005-02-10 Leslie Joe Dunaway Treatment of allergic rhinitis and asthma
US20070105960A1 (en) * 2003-08-27 2007-05-10 Eli Lilly And Company Treatment of learning disabilities and motor skills disorder with norepinephrine reuptake inhibitors
KR20060121178A (ko) * 2003-12-12 2006-11-28 일라이 릴리 앤드 캄파니 일과성 전신 열감, 충동 조절 장애 및 일반적인 의학상태로 인한 인격 변화 치료용 선택적 노르에피네프린재흡수 억제제
AP2006003771A0 (en) * 2004-04-30 2006-10-31 Warner Lambert Co Substituted morpholine compounds for the treatmentof central nervous system disorders
US7439399B2 (en) * 2004-06-28 2008-10-21 Teva Pharmaceutical Fine Chemicals Processes for the preparation of atomoxetine hydrochloride
US8580776B2 (en) * 2007-07-10 2013-11-12 The Board Of Trustees Of The University Of Illinois Compositions and methods for treating neurodegenerating diseases
US20100069389A1 (en) * 2008-09-06 2010-03-18 Bionevia Pharmaceuticals, Inc. Novel forms of reboxetine
US20100317730A1 (en) * 2009-06-12 2010-12-16 Shaya Elias K Treatment for menopausal and perimenopausal vasomotor symptons
TW201107485A (en) * 2009-07-31 2011-03-01 Univ Nat Taiwan Treating negative symptoms of schizophrenia associated with defective neuregulin 1 (NRG1)
US20140249180A1 (en) * 2011-10-03 2014-09-04 National Center For Geriatrics And Gerontology Tau aggregation inhibitor
US10154988B2 (en) 2012-11-14 2018-12-18 The Johns Hopkins University Methods and compositions for treating schizophrenia
EP2962687B1 (en) 2013-04-02 2019-06-05 The Doshisha Tau aggregation inhibitor

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4314081A (en) * 1974-01-10 1982-02-02 Eli Lilly And Company Arloxyphenylpropylamines
US5281624A (en) * 1991-09-27 1994-01-25 Eli Lilly And Company N-alkyl-3-phenyl-3-(2-substituted phenoxy) propylamines and pharmaceutical use thereof
US5658590A (en) * 1995-01-11 1997-08-19 Eli Lilly And Company Treatment of attention-deficit/hyperactivity disorder
ATE305788T1 (de) * 1999-07-01 2005-10-15 Pharmacia & Upjohn Co Llc (s,s)-reboxetin zur behandlung von inkontinenz
SK4732002A3 (en) * 1999-10-13 2002-12-03 Pfizer Prod Inc Biaryl ether derivatives useful as monoamine reuptake inhibitors
WO2002053104A2 (en) * 2001-01-02 2002-07-11 Sention, Inc. Use of catecholamine reuptake inhibitors to enhance memory
MXPA03006003A (es) * 2001-01-02 2005-09-08 Upjohn Co Nuevas combinaciones de farmacos.

Also Published As

Publication number Publication date
PL369311A1 (en) 2005-04-18
NO20042904L (no) 2004-09-07
JP2005517647A (ja) 2005-06-16
AU2002352625A1 (en) 2003-06-23
ES2295435T3 (es) 2008-04-16
SK2442004A3 (en) 2004-12-01
MY136367A (en) 2008-09-30
MXPA04005716A (es) 2004-12-06
CN1713900A (zh) 2005-12-28
HUP0402619A3 (en) 2008-04-28
BR0213581A (pt) 2004-08-24
CZ2004709A3 (cs) 2004-10-13
HUP0402619A2 (hu) 2005-03-29
EP1458368B1 (en) 2007-11-21
EP1458368A1 (en) 2004-09-22
ZA200404274B (en) 2005-09-13
HRPK20040528B3 (en) 2006-03-31
NZ532065A (en) 2007-03-30
US20050009925A1 (en) 2005-01-13
DE60223718D1 (de) 2008-01-03
DE60223718T2 (de) 2008-10-30
CO5590907A2 (es) 2005-12-30
KR20040066895A (ko) 2004-07-27
WO2003049724A1 (en) 2003-06-19
CA2467802A1 (en) 2003-06-19
EA200400793A1 (ru) 2004-10-28
TW200300672A (en) 2003-06-16
HRP20040528A2 (en) 2004-10-31
IL161989A0 (en) 2005-11-20

Similar Documents

Publication Publication Date Title
LTC1436271I2 (lt) Fenilpiperazino dariniai, kaip serotonino grįžtamos absorbcijos inhibitoriai
HRP20050467A2 (en) Combination of beta-3-receptor agonist and a balanced dual reuptake inhibitor of serotonine and norepinephrine
NO20034307L (no) Cyklopropylindol-derivater som selektive serotonin- gjenopptaksinhibitorer
MXPA03010134A (es) Derivados de ciclohexan-1-4-diamina sustituidos.
BR0114903A (pt) 7-azaindóis, sua aplicação como inibidores da fosfodiesterase 4 e processos para a sua preparação
BRPI0416268A (pt) composições de delta-9-thc e métodos para o tratamento de sintomas associados à esclerose múltipla
CY1110130T1 (el) Παραγωγα μορφολινης για χρηση ως αγωνιστες ντοπαμινης στην θεραπευτικη αγωγη σεξουαλικης δυσλειτουργιας i.α.
BRPI0112375B8 (pt) aplidinas como derivados antitumorais
HRP20080057T3 (en) 9,10-alpha,alpha-oh-taxane analogs and methods for production thereof
EE200400005A (et) Tablett, mis sisaldab vähemalt kahte eristatavat segmenti ning selle kasutamine
BR0213581A (pt) Uso de um inibidor de recaptação de norepinefrina seletivo
BRPI0415390A (pt) compostos de pirazinona substituìda para o tratamento da inflamação
EA200602157A1 (ru) Новые производные тетрагидропиридотиофена
BR0115301A (pt) Uso de um inibidor seletivo da recaptação de norepinefrina
MX244730B (es) Catalizadores para oxocloruracion del etileno a 1,2-dicloretano.
ATE345135T1 (de) Tropan-derivate mit dopamin-wiederaufnahme-hemmer-wirkung für die behandlung von ischämischen erkrankungen
DK1177191T3 (da) Substituerede benzimidazoler, fremstilling og anvendelse deraf som midler til bekæmpelse af parasitiske protozoer
BR0205194B1 (pt) disposição de trilhos de guia para elevadores.
DE60323748D1 (de) 1,3-diaza-dibenzoazulene als inhibitoren der produfür deren herstellung
NO20061425L (no) Kombinasjonen av en serotonin-reopptaksinbibitor og loxapin
CR7368A (es) Uso de inhibidores de la recaptacion de norepinefrina para el tratamiento del fallo cognitivo
NO20062700L (no) Morfolinderivater som norepinefrin reopptaksinhibitorer
ITMI20021328A1 (it) Nuove piperazine 1,4 - disostituite
ATE338046T1 (de) 2-(aminomethyl)-tetrahydro-9-oxa-1,3-diaza- cyclopenta(a)naphthalenyl derivate mit antipsychotischer aktivität
IL284547A (en) 3 balls with lighting and air conditioning